Clinical Trials Browser

Phase 1/2 × Refractory Desmoplastic Small Round Cell Tumors × Imatinib Mesylate × Clear all

NCT00417807 2010-12-24

Imatinib Mesylate in Patients With Refractory Desmoplastic Small Round Cell Tumors

Phase 1/2 Completed

Refractory Desmoplastic Small Round Cell Tumors